Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361958517> ?p ?o ?g. }
- W4361958517 abstract "<div>AbstractPurpose:<p>In a head and neck squamous cell carcinoma (HNSCC) “window of opportunity” clinical trial, we reported that trametinib reduced MEK-Erk1/2 activation and resulted in tumor responses in a subset of patients. Here, we investigated resistance to trametinib and molecular correlates in HNSCC cell lines and patient samples.</p>Experimental Design:<p>HNSCC cell lines were treated with trametinib to generate resistant lines. Candidate bypass pathways were assessed using immunoblotting, CRISPR knockout, and survival assays. Effectiveness of combined trametinib and verteporfin targeting was evaluated. Patient-derived xenografts (PDXs) from responder patients were treated with trametinib and resistant tumors were analyzed. Window trial clinical samples were subjected to whole-exome and RNA sequencing.</p>Results:<p>HNSCC cell lines developed resistance (CAL27-TR and HSC3-TR) after prolonged trametinib exposure. Downstream effectors of the Hippo pathway were activated in CAL27-TR and HSC3-TR, and combined trametinib and verteporfin treatment resulted in synergistic treatment response. We defined the Hippo pathway effector Yap1 as an induced survival pathway promoting resistance to trametinib in HSC3-TR. Yap1 was necessary for HSC3-TR trametinib resistance, and constitutively active Yap1 was sufficient to confer resistance in parental HSC3. Analysis of trametinib neoadjuvant trial patient tumors indicated canonical MEK-Erk1/2 pathway activating mutations were infrequent, and Yap1 activity increased following trametinib treatment. Trametinib treatment of a PDX from a responder patient resulted in evolution of resistance with increased Yap1 expression and activity.</p>Conclusions:<p>These studies identify a Yap1-dependent resistance to trametinib therapy in HNSCCs. Combined Yap1 and MEK targeting may represent a strategy to enhance HNSCC response.</p></div>" @default.
- W4361958517 created "2023-04-05" @default.
- W4361958517 creator A5019133023 @default.
- W4361958517 creator A5020521476 @default.
- W4361958517 creator A5022139249 @default.
- W4361958517 creator A5024262059 @default.
- W4361958517 creator A5035700326 @default.
- W4361958517 creator A5036890758 @default.
- W4361958517 creator A5047966818 @default.
- W4361958517 creator A5049794515 @default.
- W4361958517 creator A5052134884 @default.
- W4361958517 creator A5060148176 @default.
- W4361958517 creator A5064319129 @default.
- W4361958517 creator A5066002385 @default.
- W4361958517 creator A5076166380 @default.
- W4361958517 creator A5078011541 @default.
- W4361958517 creator A5083874204 @default.
- W4361958517 date "2023-03-31" @default.
- W4361958517 modified "2023-10-14" @default.
- W4361958517 title "Data from Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas" @default.
- W4361958517 doi "https://doi.org/10.1158/1078-0432.c.6530613.v1" @default.
- W4361958517 hasPublicationYear "2023" @default.
- W4361958517 type Work @default.
- W4361958517 citedByCount "0" @default.
- W4361958517 crossrefType "posted-content" @default.
- W4361958517 hasAuthorship W4361958517A5019133023 @default.
- W4361958517 hasAuthorship W4361958517A5020521476 @default.
- W4361958517 hasAuthorship W4361958517A5022139249 @default.
- W4361958517 hasAuthorship W4361958517A5024262059 @default.
- W4361958517 hasAuthorship W4361958517A5035700326 @default.
- W4361958517 hasAuthorship W4361958517A5036890758 @default.
- W4361958517 hasAuthorship W4361958517A5047966818 @default.
- W4361958517 hasAuthorship W4361958517A5049794515 @default.
- W4361958517 hasAuthorship W4361958517A5052134884 @default.
- W4361958517 hasAuthorship W4361958517A5060148176 @default.
- W4361958517 hasAuthorship W4361958517A5064319129 @default.
- W4361958517 hasAuthorship W4361958517A5066002385 @default.
- W4361958517 hasAuthorship W4361958517A5076166380 @default.
- W4361958517 hasAuthorship W4361958517A5078011541 @default.
- W4361958517 hasAuthorship W4361958517A5083874204 @default.
- W4361958517 hasBestOaLocation W43619585172 @default.
- W4361958517 hasConcept C104317684 @default.
- W4361958517 hasConcept C121608353 @default.
- W4361958517 hasConcept C126322002 @default.
- W4361958517 hasConcept C172512520 @default.
- W4361958517 hasConcept C203014093 @default.
- W4361958517 hasConcept C2776530083 @default.
- W4361958517 hasConcept C2776833033 @default.
- W4361958517 hasConcept C2778472372 @default.
- W4361958517 hasConcept C2780219982 @default.
- W4361958517 hasConcept C2780827179 @default.
- W4361958517 hasConcept C2781148688 @default.
- W4361958517 hasConcept C2781249067 @default.
- W4361958517 hasConcept C2781359195 @default.
- W4361958517 hasConcept C502942594 @default.
- W4361958517 hasConcept C51785407 @default.
- W4361958517 hasConcept C54355233 @default.
- W4361958517 hasConcept C55493867 @default.
- W4361958517 hasConcept C57074206 @default.
- W4361958517 hasConcept C62478195 @default.
- W4361958517 hasConcept C71924100 @default.
- W4361958517 hasConcept C86339819 @default.
- W4361958517 hasConcept C86803240 @default.
- W4361958517 hasConcept C95444343 @default.
- W4361958517 hasConceptScore W4361958517C104317684 @default.
- W4361958517 hasConceptScore W4361958517C121608353 @default.
- W4361958517 hasConceptScore W4361958517C126322002 @default.
- W4361958517 hasConceptScore W4361958517C172512520 @default.
- W4361958517 hasConceptScore W4361958517C203014093 @default.
- W4361958517 hasConceptScore W4361958517C2776530083 @default.
- W4361958517 hasConceptScore W4361958517C2776833033 @default.
- W4361958517 hasConceptScore W4361958517C2778472372 @default.
- W4361958517 hasConceptScore W4361958517C2780219982 @default.
- W4361958517 hasConceptScore W4361958517C2780827179 @default.
- W4361958517 hasConceptScore W4361958517C2781148688 @default.
- W4361958517 hasConceptScore W4361958517C2781249067 @default.
- W4361958517 hasConceptScore W4361958517C2781359195 @default.
- W4361958517 hasConceptScore W4361958517C502942594 @default.
- W4361958517 hasConceptScore W4361958517C51785407 @default.
- W4361958517 hasConceptScore W4361958517C54355233 @default.
- W4361958517 hasConceptScore W4361958517C55493867 @default.
- W4361958517 hasConceptScore W4361958517C57074206 @default.
- W4361958517 hasConceptScore W4361958517C62478195 @default.
- W4361958517 hasConceptScore W4361958517C71924100 @default.
- W4361958517 hasConceptScore W4361958517C86339819 @default.
- W4361958517 hasConceptScore W4361958517C86803240 @default.
- W4361958517 hasConceptScore W4361958517C95444343 @default.
- W4361958517 hasLocation W43619585171 @default.
- W4361958517 hasLocation W43619585172 @default.
- W4361958517 hasOpenAccess W4361958517 @default.
- W4361958517 hasPrimaryLocation W43619585171 @default.
- W4361958517 hasRelatedWork W2962823878 @default.
- W4361958517 hasRelatedWork W2986966718 @default.
- W4361958517 hasRelatedWork W3047219078 @default.
- W4361958517 hasRelatedWork W3126871726 @default.
- W4361958517 hasRelatedWork W3144492700 @default.
- W4361958517 hasRelatedWork W4200594359 @default.
- W4361958517 hasRelatedWork W4361843741 @default.
- W4361958517 hasRelatedWork W4361843751 @default.
- W4361958517 hasRelatedWork W4361947415 @default.